Centennial (IV) of the Communist Party of China
Release time:
2021-04-12
1936 12 12 , in order to stop the civil war and unite against Japan, Zhang Xueliang and Yang Hucheng detained Chiang Kai-shek in Lintong and launched "Xi 'an Incident " , which shocked China and foreign countries. With the efforts of the CPC Central Committee, Chiang Kai-shek was forced to accept "to stop the civil war and " on 24 . The peaceful settlement of the Xi'an Incident played a major role in promoting the cooperation between the Kuomintang and the Communist Party and uniting against Japan. It became a turning point from the civil war to the anti-Japanese national war.
1937 9 , the Kuomintang and the Communist Party realized the second cooperation, and the anti-Japanese national united front with the cooperation between the Kuomintang and the Communist Party as the main body was formally formed.
1937 9 May 25 , the Eighth Route Army 115 Division concentrated a large force in Pingxingguan to ambush the Japanese army, winning the first victory, delaying the Japanese army's strategic attack and disrupting the enemy's plan.
1938 5# In April, Mao Zedong published "On Protracted War". On the basis of summarizing the early experience of the Anti-Japanese War and comprehensively analyzing the characteristics of the enemy and ourselves, he demonstrated the development law of the Anti-Japanese War and systematically expounded China's strategy of carrying out protracted war to win the war against Japan. Criticized "Theory of Subjugation " and "Theory of Quick Victory " and other misunderstandings against the Anti-Japanese War, and made scientific predictions on the development process of the Anti-Japanese War. This work has ideologically armed the whole party, the whole army and the masses of the people, strengthened the confidence of the Chinese people in winning the war of resistance against Japan, and is the theoretical program for guiding the national war of resistance against Japan.
19408 July 20 , the Eighth Route Army launched a "100 Regiment War " of 105 regiments in North China. This battle was fought 1820 times, killing and injuring more than 25800 Japanese puppet troops and capturing a large number of puppet troops and Japanese troops, it destroyed a large number of enemy forts, strongholds, and facilities, strengthened the confidence of the people of the whole country in the victory of the Anti-Japanese War, enhanced the prestige of the Communist Party of China and the eighth Route Army, and played a positive role in persisting in the Anti-Japanese War, curbing the undercurrent of compromise and surrender, and striving for a better situation.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page